What comorbidities are associated with a bicuspid aortic valve?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Comorbidities Associated with Bicuspid Aortic Valve

Bicuspid aortic valve (BAV) is primarily associated with progressive valvular dysfunction (aortic stenosis and regurgitation), thoracic aortic dilatation/aortopathy, mitral valve prolapse, aortic coarctation, infective endocarditis, and aortic dissection, with specific cardiomyopathies occurring in approximately 5-6% of patients.

Primary Valve-Related Complications

The most common complications occur in order of frequency 1:

  • Aortic stenosis requiring surgical intervention (most common)
  • Ascending thoracic aortic dilatation requiring surgical repair
  • Aortic regurgitation requiring surgical intervention
  • Mitral valve prolapse (including anterior leaflet involvement that may require surgery) 1
  • Infective endocarditis 1
  • Aortic dissection (rare in pediatric populations and adults without aortic dilatation) 1

Aortopathy Phenotypes

BAV-associated aortopathy manifests as thoracic aorta dilatation in three distinct patterns 1:

  • Ascending phenotype (most common)
  • Root phenotype
  • Extended phenotypes

The aortic wall demonstrates severe noninflammatory degenerative changes including elastic fiber fragmentation, smooth muscle cell death, and mucoid extracellular matrix accumulation, creating intrinsic weakness that leads to progressive aneurysmal dilatation independent of valve dysfunction 2.

Congenital Cardiac Associations

Complex presentations are associated with 1:

  • Aortic coarctation (significant association providing evidence for shared embryologic origin)
  • Left-sided obstructions
  • Various syndromes

These complex forms are more commonly diagnosed in childhood, adolescence, and young adulthood, presenting with early/accelerated valve dysfunction and early aortopathy 1.

Specific Cardiomyopathies

Concomitant cardiomyopathies occur in 5.6% of BAV patients 3:

  • Left ventricular non-compaction (3.4%) - predominantly in younger males with greater BAV dysfunction
  • Hypertrophic cardiomyopathy (1.4%) - associated with higher diabetes prevalence and heart failure with preserved ejection fraction
  • Dilated cardiomyopathy (0.8%) - associated with chronic kidney disease and heart failure with reduced ejection fraction

The presence of cardiomyopathy is independently associated with heart failure (odds ratio 2.795) 3.

Clinical Pitfalls

Critical distinction: BAV exists on a spectrum from "typical" presentations (diagnosed in young/middle-aged adults with progressive valvular dysfunction and high cumulative incidence of aortopathy) to "complex" presentations (associated with syndromes and congenital lesions) to "uncomplicated" forms (never causing complications requiring treatment) 1.

Surveillance imperative: The condition has significant genetic components requiring screening of first-degree relatives 2. Despite high cardiac event rates, state-of-the-art care results in good survival (94.5% at 10 years) with low rates of infective endocarditis, aortic dissection, and sudden death when properly monitored 4.

Predictors of adverse events: Incremental degrees of stenosis and regurgitation, baseline aortic dilatation ≥40mm, and age independently predict cardiac events 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.